PEPTIDES HAVING CAPACITY TO BIND WITH SCURFIN AND USE THEREOF Russian patent published in 2013 - IPC C07K7/08 C12N15/63 C12N1/11 A61K38/04 A61K39/39 

Abstract RU 2502741 C2

FIELD: chemistry.

SUBSTANCE: invention relates to a peptide capable of binding with scurfin and inhibiting biological activity of scurfin, which is selected from a peptide consisting of an amino acid sequence Arg-Asp-Phe-Gln-Ser-Phe-Arg-Lys-Met- Trp-Pro-Phe-Phe-X, where X is absent or X is present and represents X14 or X14-X15, where X14 and X15 independently denote an amino acid, a version of said peptide and a pharmaceutically acceptable salt thereof. The invention also discloses a fused protein and a pharmaceutical composition, which involves use of said peptide and fused protein, as well as use thereof to produce and treat pathologies which require transient regulation or inhibition of immunosuppressive activity of regulatory T lymphocytes, such as a neoplastic disease or infectious disease. The invention also relates to a method of producing said peptide and fused protein, including a protein or peptide coding nucleic acid, a DNA construct, an expression vector and a host cell.

EFFECT: invention provides effective treatment of infectious and neoplastic diseases which require transient regulation or inhibition of immunosuppressive activity of regulatory T lymphocytes.

26 cl, 10 dwg, 5 ex

Similar patents RU2502741C2

Title Year Author Number
ACTIVATOR OF REGULATORY T CELLS AND USE THEREOF 2017
  • Sibuya Akira
  • Sibuya Kazuko
  • Abe Fumie
  • Khirotika Rei
  • Okumura Genki
RU2736650C2
PEPTIDE CAPABLE OF BINDING WITH β AND INHIBITING BIOLOGICAL ACTIVITY OF β IN VITRO AND/OR IN VIVO, APPLICATION OF PEPTIDE, PHARMACEUTICAL COMPOSITION, DNA SEQUENCE, DNA STRUCTURE, EXPRESSION VECTOR, HOST-CELL AND METHOD OF OBTAINING PEPTIDE 2004
  • Dotor De Las Ehrrerias Khav'Er
  • Lopes Vaskes Ana Belen
  • Lasarte Sagastibel'Sa Khuan Khose
  • Pr'Eto Val'Tuehn'Ja Khesus
  • Borras Kuehsta Fransisko
RU2333917C2
USE OF DNA SEQUENCE WHICH CODES PEPTIDE ABLE TO BIND WITH TRANSFORMING GROWTH FACTOR β1 (VERSIONS) 2008
  • Dotor De Las Ehrrerias Khav'Er
  • Lopes Vaskes Ana Belen
  • Lasarte Sagastibel'Sa Khuan Khose
  • Pr'Eto Val'Tuehn'Ja Khesus
  • Borras Kuehsta Fransisko
RU2455358C2
MONOCLONAL ANTIBODY SUPPRESSING THE IMMUNOSUPPRESSIVE FUNCTIONS OF PATHOGENS, ANTIGEN-BINDING FRAGMENT OF THE SPECIFIED ANTIBODY AND HYBRIDOMAS PRODUCING THE SPECIFIED ANTIBODY 2017
  • Lyao Kuan-Ven
  • Lin Yuj-Lin
  • Tszyan Tin-Yan
RU2751918C2
FUSED POLYPEPTIDE WITH ANTICANCER ACTIVITY 2016
  • Hinner Marlon
  • Rothe Christine
  • Olwill Shane
  • Bel Aiba Rachida Siham
  • Moebius Ulrich
  • Schlosser Corinna
  • Jaquin Thomas Jean
RU2727165C2
HUMAN LIPOCALIN 2 MUTEINS (Lcn2, hNGAL) WITH TARGETED AFFINITY 2019
  • Skerra Arne
  • Gebauer Michaela
  • Hinz Dominik
  • Rauth Sabine
  • Matschiner Gabriele
  • Huelsmeyer Martin
RU2804336C2
IMMUNOSUPPRESSIVE POLYPEPTIDES AND NUCLEIC ACIDS 2008
  • Karrer Ehrik E.
  • Pejdkhungat Madan M.
  • Bejs Stiven Kh.
  • Nejbors Margaret
  • Punnonen Jukha
  • Chepin Stiven Dzh.
  • Visvanatkhan Sridkhar
  • Larsen Brent R.
RU2506275C2
MUTEINS OF HUMAN LIPOCALIN 2 (LCN2, HNGAL) WITH AFFINITY TO CERTAIN TARGET 2010
  • Skerra Arne
  • Gebauehr Mikhaehla
  • Khints Dominik
  • Raut Zabine
  • Machiner Gabriehle
  • Khjul'Smejer Martin
RU2564125C2
HUMAN LIPOLOCAL 2 MALLETES (LCN2, HNGAL) WITH AFFINITY FOR SPECIFIC TARGET 2010
  • Skerra Arne
  • Gebauer Mikhaela
  • Khints Dominik
  • Raut Zabine
  • Machiner Gabriele
  • Khyulsmejer Martin
RU2707126C2
DPPIV-COGNATED NEW SERINE PROTEASE GENE 2001
  • Ki Stiv
  • Akinsan'Ja Karen O.
  • Riv'Er P'Er Zh.-M.
  • Zhjun'En Zhan-Lui
RU2305133C2

RU 2 502 741 C2

Authors

Kasares Lagar Ines Noehlija

Borras Kuehsta Fransisko

Sarobe Ugarrisa Pablo

Prieto Valtuehn'Ja Khesus

Lasarte Sagastibel'Sa Khuan Khose

Dates

2013-12-27Published

2008-11-14Filed